Ovarian Vein Thrombosis: Laterality and Management in Pregnancy
Ovarian vein thrombosis occurs predominantly on the RIGHT side (70-80% of cases), and pregnant patients should be treated with therapeutic-dose low-molecular-weight heparin (LMWH) for 3-6 months, combined with broad-spectrum antibiotics if fever is present 1, 2.
Anatomic Laterality
The right ovarian vein is involved in 70-80% of cases, the left in less than 6%, and bilateral involvement occurs in approximately 14% of cases 2, 3. This right-sided predominance is attributed to anatomic factors: the right ovarian vein is longer, has incompetent valves, and experiences retrograde flow from the inferior vena cava during pregnancy 1, 2.
Clinical Recognition in Pregnancy
Ovarian vein thrombosis complicates 0.01-0.18% of pregnancies and typically presents 2-6 days postpartum 2. The classic triad includes:
- Lower abdominal pain (most common presenting symptom)
- Fever unresponsive to antibiotics alone (occurs in ~23-33% of puerperal fever cases)
- Leukocytosis
A palpable abdominal mass is present in only 46% of cases 2. Critical pitfall: The presentation mimics appendicitis, endometritis, or pelvic abscess, leading to diagnostic delays 4, 5.
Diagnostic Approach
Computed tomography (CT) or magnetic resonance imaging (MRI) are required for definitive diagnosis, with MRI demonstrating the best diagnostic performance 6. While ultrasound Doppler is first-line due to safety in pregnancy, it has limited sensitivity due to bowel gas and obesity 2. The imaging must visualize the entire ovarian vein to assess for extension to the renal vein (9.6% of cases), inferior vena cava (10.3%), or iliac veins (5.9%) 6.
Management Protocol
Anticoagulation Strategy
For pregnant women with acute ovarian vein thrombosis, initiate therapeutic-dose LMWH immediately 7. The ASH 2018 guidelines provide strong recommendations (moderate certainty evidence) for LMWH over unfractionated heparin in all pregnancy-related VTE 7.
Specific dosing considerations:
- Either once-daily or twice-daily LMWH dosing is acceptable (conditional recommendation) 7
- Routine anti-Xa monitoring is NOT recommended unless there are comorbidities affecting clearance (renal disease, extremes of body weight, or antithrombin deficiency) 8, 7
- Duration: 3-6 months of anticoagulation is standard for postpartum ovarian vein thrombosis 2, 6
Antibiotic Therapy
Administer broad-spectrum intravenous antibiotics until at least 48 hours after fever resolution 2, 5. This addresses the inflammatory/infectious component that often accompanies ovarian vein thrombosis, particularly in the postpartum setting.
Multidisciplinary Coordination
Involve both maternal-fetal medicine (MFM) and hematology/thrombosis specialists for newly diagnosed VTE in pregnancy 8. The complexity of ovarian vein thrombosis—with its potential for extension to major vessels and risk of pulmonary embolism (6.5% of cases)—warrants subspecialty input 6. Follow-up should occur within one week of diagnosis to assess for progression, medication adherence, and complications 8.
Delivery Planning
For women on therapeutic LMWH, schedule delivery with planned discontinuation of anticoagulation (conditional recommendation) 7. This allows for neuraxial anesthesia if desired and reduces bleeding risk at delivery.
Complications to Monitor
- Pulmonary embolism: 6.5% incidence 6
- Sepsis: Can occur if infection is undertreated 3
- Extension to renal vein or IVC: Requires imaging surveillance 4, 6
- Recurrent thrombosis: 8% rate, though recanalization occurs in 70% 6
- Major bleeding: 2% with anticoagulation 6
Thrombophilia Testing
Test for thrombophilia in women with ovarian vein thrombosis, as 18% have an underlying thrombophilic condition 6. This influences long-term management and counseling for future pregnancies.
Common Pitfalls
- Misdiagnosing as appendicitis or endometritis due to right lower quadrant pain and fever—maintain high suspicion in postpartum women with persistent fever despite antibiotics 4, 5
- Relying solely on ultrasound—proceed directly to CT/MRI if clinical suspicion is high 2, 6
- Undertreating with prophylactic-dose anticoagulation—ovarian vein thrombosis requires therapeutic dosing as it is a true VTE 2
- Premature discontinuation of anticoagulation—complete the full 3-6 month course 2, 6